Heart disease isn't always obvious, and sometimes you have little to no warning leading up to a catastrophic event.

Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

The US Food and Drug Administration (FDA) has given the greenlight to Caristo Diagnostics for CaRi-Plaque, an artificial ...

When coronary computed tomography angiography ... arteries for plaque burden. CCTA is a noninvasive diagnostic test that combines X-ray and other technology to produce detailed, three-dimensional ...

Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, ...

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...

By enabling calcium scoring from widely available imaging ... using coronary computed tomography angiography (CCTA) scans to noninvasively assess the likelihood of coronary artery disease at ...

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

BOUNTIFUL — Andra Lalli, 65, leads an active lifestyle. She enjoys going to the gym and has taught fitness classes for years — which is why when she went in for a heart scan, her results were ...

FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...

Kennesaw State University researcher Chen Zhao has earned the 2025 American Heart Association Institutional Research Enhancement Award. The $194,032 award will allow Zhao to continue developing ...

Coronary artery calcium tests are one the newer tools doctors can use to predict a person's chances of developing cardiovascular problems. "It's a very simple test," Dickerson said. "It's a CT scan ...